BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 17, 2003
View Archived Issues
ETB receptors and GIRKs: novel targets for the treatment of pain
Read More
New GSK-3 inhibitors with potential in diabetes, etc.
Read More
Gruenenthal patent covers new compounds for pain, depression, etc.
Read More
Shionogi researchers describe a novel series of HIV integrase inhibitors
Read More
New ADAM-10 inhibitors and their use in cancer and arthritis described by Exelixis
Read More
Novel NK1 antagonists for urinary incontinence and other uses in Kyorin pipeline
Read More
Noncalcemic vitamin D analogue designed by Wisconsin researchers
Read More
New anthelminthic agents patented by Kitasato Institute scientists
Read More
BMS-387032: a potent and selective CDK2 inhibitor undergoing clinical evaluation
Read More
Decolonization of the GI tract with ramoplanin: a novel option for management of VRE infection
Read More
Preclinical pharmacological activity of the novel aromatase inhibitor MEN-11066
Read More
Chiron presents antiangiogenic and antiproliferative agent targeting growth factor tyrosine kinases
Read More
Ariad compound for bone cancer/metastases a highlight of the AACR meeting
Read More
H3 Pharma acquires rights to vapreotide from Debiopharm
Read More
Patient dosing begins in Targeted Genetics' largest CF trial to date
Read More
Improved efficacy for niacin/lovastatin on lipid profile in hyperlipidemia
Read More
Santarus completes phase III patient enrollment in upper GI bleeding prevention trial
Read More
IX-1003 completes phase I testing
Read More
HCV-371 has no impact on HCV RNA levels in phase Ib study
Read More
Effective inhibition of thrombosis and moderate hemorrhage risk with melagatran in baboons
Read More
Pivotal European study of Adhibit commences enrollment
Read More
Better survival and response rate found with letrozole vs. tamoxifen in advanced breast cancer
Read More
Relationship between breast cancer risk and isoflavone consumption in Japanese women
Read More
Kosan achieves KOS-862 production goal
Read More